European Crohn’s and Colitis Organisation Topical Review on Treatment Withdrawal [‘Exit Strategies’] in Inflammatory Bowel Disease-Reference-Cited by-同舟云学术

European Crohn’s and Colitis Organisation Topical Review on Treatment Withdrawal [‘Exit Strategies’] in Inflammatory Bowel Disease

Published:2017-08-02 Issue:1 Volume:12 Page:17-31
ISSN:1873-9946
Container-title:Journal of Crohn's and Colitis
language:en
Short-container-title:

Author:

Doherty Glen,Katsanos Konstantinos H,Burisch Johan,Allez Matthieu,Papamichael Konstantinos,Stallmach Andreas,Mao Ren,Berset Ingrid Prytz,Gisbert Javier P,Sebastian Shaji,Kierkuś Jarosław,Lopetuso Loris,Szymanska Edyta,Louis Edouard

Publisher

Oxford University Press (OUP)

Subject

Gastroenterology,General Medicine

Link

http://academic.oup.com/ecco-jcc/article-pdf/12/1/17/23265511/jjx101.pdf

Reference169 articles.

1. Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study;CESAME Study Group;Lancet,2009

2. Increased risk for nonmelanoma skin cancers in patients who receive thiopurines for inflammatory bowel disease;Cesame Study Group;Gastroenterology,2011

3. Increased risk of acute myeloid leukemias and myelodysplastic syndromes in patients who received thiopurine treatment for inflammatory bowel disease;CESAME Study Group;Clin Gastroenterol Hepatol,2014

4. Excess risk of urinary tract cancers in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study;CESAME study group;Aliment Pharmacol Ther,2016

5. Perception gaps between patients with ulcerative colitis and health care professionals: an online survey;BMC Gastroenterol,2012

Cited by 164 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Common Mistakes in Managing Patients with Inflammatory Bowel Disease;Journal of Clinical Medicine;2024-08-14

2. Patients with ulcerative colitis who have normalized histology are clinically stable after de-escalation of therapy;npj Gut and Liver;2024-08-02

3. Design strategies, advances and future perspectives of colon-targeted delivery systems for the treatment of inflammatory bowel disease;Asian Journal of Pharmaceutical Sciences;2024-08

4. De-escalating therapy in inflammatory bowel disease: Results from an observational study in clinical practice;Gastroenterología y Hepatología (English Edition);2024-08

5. Gas-propelled nanomotors alleviate colitis through the regulation of intestinal immunoenvironment-hematopexis-microbiota circuits;Acta Pharmaceutica Sinica B;2024-06